Last reviewed · How we verify

NCT04934449: bruxism

Occlusal Splints in the Treatment of Sleep Bruxism

Completed NA Last updated 22 June 2022
What this trial tests

NA trial testing Occlusal splint in Sleep Bruxism, Adult in 100 participants. Completed in 14 December 2021.

Timeline
6 August 2021
Primary endpoint
12 December 2021
14 December 2021

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date6 August 2021
Primary completion12 December 2021
Estimated completion14 December 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 18 to 65, any sex, with Sleep Bruxism, Adult or Splints. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Occlusal splints are employed in the treatment of sleep bruxism. These appliances decrease sleep-related actions and damages bruxism, like grinding, tooth-wear, headache, and temporomandibular joint disorders. Occlusal splints are produced both in hard and soft forms according to the used material. In this study, it was aimed to evaluate the effect of occlusal splint type on the sleep quality and occlusal force parameters of patients with sleep bruxism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Occlusal splint

Trials testing the same drug.

Other recruiting trials for Sleep Bruxism, Adult

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04934449.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing